Cite
HARVARD Citation
Langley, R. et al. (2019). Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials. British journal of dermatology. pp. 306-314. [Online].